An open-label randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury

Chinese Journal of Antituberculosis ›› 2016, Vol. 38 ›› Issue (1): 23-31.doi: 10.3969/j.issn.1000-6621.2016.01.007

Previous Articles Next Articles

An open-label randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury

Online:2016-01-10 Published:2016-03-07

Abstract

References

Related Articles 0

Recommended Articles

Metrics

Comments